Attending Clinical Trials Europe 2022? So is Clinical ink. Gather with us and "Future-Proof Your Strategies to Ensure Clinical Trial Success: Decentralized Trials, Digital Health, […]
Attending the European Site Solutions Summit? So is Clinical ink, as an SCRS Global Impact Partner. The SCRS European Site Solutions Summit is the best […]
Attending the CNS Summit 2022? Clinical ink is an Executive Patron, and will be in attendance, exhibiting, and presenting. Visit us at booth #48 to […]
Attending the Outsourcing in Clinical Trials DACH 2022? Clinical ink will be in attendance, come find us at booth #4. This event will focus on […]
Over four stimulating days of in-depth discussions in 28 different conferences, 3 plenary keynote sessions, the 7th annual Participant Engagement Awards, special cross-department panels, the […]
For the 15th Annual event, the flagship OCT show will focus on providing delegates with practical take-aways and solutions to their most current operational and […]
How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? […]
Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research Parkinson's Disease and Movement Disorder research is accelerating […]
11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central) Systemic Lupus Erythematosus (SLE) clinical trials are complex and can be challenging to conduct. […]
For years, diabetes clinical trials have been trailing clinical care because of regulatory and logistical challenges with utilizing CGMs in a clinical trial setting. But, because of recent FDA clearance of commercially available devices, these CGM devices have started to be implemented more widely in the clinical trial setting – at least in the United States – but global trials still present challenges.
Don't miss Clinical ink Principal Scientist David Anderson on "Predicting ALS Progression in Remote Sensor-Based Assessments" at the International Congress of Parkinson’s Disease and Movement […]
In this informative webinar, discover strategies for patient engagement and digital therapeutics relating to the management of social determinants of health in cardiometabolic diseases and recent Food and Drug Administration (FDA) guidance on the future of Lupus research.
Sales and Solutions
Direct 1.336.464.0697
Support
Toll-Free 1.800.301.5033
Direct 1.336.464.0697
Insert HTML text here.
Request more information, submit questions, set up a demonstration, and more.
